Ananda Pharma secures ethics approval for MRX1 trial - ICYMI
Ananda Pharma Plc (AQSE:ANA) has secured ethics approval to begin its first human trial of MRX1, a key milestone for the company’s therapeutic pipeline. Finance director Jeremy Sturgess-Smith noted this was the first ethics approval of its kind for any …